| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $29.70M | $26.69M | $45.04M | $25.51M | $14.54M |
| R&D | $25.22M | $20.00M | $38.79M | $16.52M | $8.48M |
| SG&A | $4.48M | $6.70M | $6.24M | $9.00M | $6.06M |
| Operating Income | -$29.70M | -$26.69M | -$45.04M | -$25.51M | -$14.54M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$28.85M | -$24.59M | -$56.20M | -$25.33M | -$14.49M |
| EPS (basic) | -1.4000 | -2.0200 | -6.2300 | -3.1000 | -1.9000 |
| EPS (diluted) | -1.4000 | -2.3100 | -6.2300 | -3.1000 | -1.9000 |
| Shares (diluted) | $20.55M | $12.24M | $9.02M | $8.16M | $7.63M |